FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a pharmaceutical composition for treating burns containing oxidised dextran of molecular weight 35-65 kDa as an active ingredient; as excipients for symptomatic therapy of burns it contains anaesthesine, polyethylene oxide of molecular weight 1.5-6.0 kDa, metronidazole, phosphatidylcholine and a pharmaceutically acceptable carrier in the following proportions, wt %: oxidized dextran - 0.5-5.0; anaesthesine - 0.5-2.5; polyethylene oxide - 0.5-5.0; metronidazole - 0.1-0.2; phosphatidylcholine - 1.0-2.0; pharmaceutically acceptable carrier - the rest. As a pharmaceutically acceptable carrier, the composition may contain purified water or physiologic saline or 10 mM phosphate buffer with pH 7.4.
EFFECT: invention provides higher clinical effectiveness in burns.
2 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
WOUND-HEALING MEANS | 2017 |
|
RU2644255C1 |
COMPOSITION FOR TREATING BURNS | 2014 |
|
RU2559087C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING TICK-BORNE ENCEPHALITIS | 2012 |
|
RU2472504C1 |
PHARMACEUTICAL TUBERCULOSIS COMPOSITION | 2008 |
|
RU2372914C1 |
AGENT FOR WOUNDS, BURNS AND INFECTIOUS INFLAMMATORY DISEASES OF SKIN, APPENDAGES AND MUCOUS MEMBRANES | 2010 |
|
RU2452475C2 |
HYDROPHILIC PHARMACEUTICAL COMPOSITION FOR TREATMENT OF BURNS (VERSIONS) | 2008 |
|
RU2404745C2 |
PHARMACEUTICAL COMPOSITION FOR TREATING FUNGOID DISEASES | 2010 |
|
RU2430730C1 |
METHOD OF TREATING BURNS IN ANIMALS | 2022 |
|
RU2808182C1 |
PHARMACEUTICAL COMPOSITION FOR IMMEDIATE TREATMENT OF BURNS OF VARIOUS ORIGINS, AREA AND DEPTH IN FORM OF SPRAY, GEL AND AEROSOL | 2014 |
|
RU2545798C1 |
METHOD OF PRODUCING BIOCOMPOSITE MATERIALS WITH REGENERATIVE AND ANTISEPTIC PROPERTIES BASED ON BACTERIAL CELLULOSE HYDROGELS | 2023 |
|
RU2814059C1 |
Authors
Dates
2013-01-27—Published
2012-03-13—Filed